Polymer Factory Sweden AB receives order of approx. SEK 400,000
Polymer Factory today announces an order of significant size, as a global biotech company has placed an order amounting to approximately SEK 400,000.
Purchasing products from Polymer Factory’s portfolio of dendritic materials, a global biotech company has placed an order of EUR 40,800, amounting to approximately SEK 413,000. The products purchased are customized to the customer and will be used by the customer for product development purposes, possibly leading to re-purchase upon successful first tests.
A single order of this size is substantial to Polymer Factory at this stage in the company growth.
CEO Elin Mignérus comments:
“Raising more interest amongst big pharma and biotech companies is well in line with the Company’s goals, and we are very glad to see that more and more customers see the benefit of using our dendritic materials in their products. We see huge potential for our library of products and will continue to work hard to make these kinds of purchases into long-term customer relationships.”
About Polymer Factory
Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.
This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 20-08-2021 16:10 CET.
For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.